4//SEC Filing
BOSTON SCIENTIFIC CORP 4
Accession 0001225208-17-000358
$BSXCIK 0000885725operating
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:20 PM ET
Size
8.7 KB
Accession
0001225208-17-000358
Insider Transaction Report
Form 4
Dawkins Keith D
Sr. VP, Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2017-01-01+11,673→ 161,900 total - Tax Payment
Common Stock
2017-01-01$21.63/sh−5,253$113,622→ 156,647 total - Exercise/Conversion
Performance Share Units
2017-01-01−11,673→ 0 totalFrom: 2016-12-31Exp: 2016-12-31→ Common Stock (11,673 underlying)
Footnotes (2)
- [F1]On February 24, 2014, the reporting person was awarded a target number of performance share units under the Company's 2014 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2014 adjusted free cash flow measured against its 2014 financial plan over the one-year performance period ending December 31, 2014 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 23, 2015, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2016.
- [F2]Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Documents
Issuer
BOSTON SCIENTIFIC CORP
CIK 0000885725
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000885725
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:20 PM ET
- Size
- 8.7 KB